| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/22/2014 | CN103520123A Cytochrome C freeze-dried powder injection solution |
| 01/22/2014 | CN103519163A Multifunctional health care product composition |
| 01/22/2014 | CN102796164B Kyotorphin modified fatty amine/alcohol derivative, and preparation method and application thereof |
| 01/22/2014 | CN102488889B Caspofungin preparation with low impurity content and preparation method and application thereof |
| 01/22/2014 | CN102382179B Peptide sequences and compositions |
| 01/22/2014 | CN102268066B Anti-HBV oligopeptides and derivatives thereof |
| 01/22/2014 | CN102241735B Polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof |
| 01/22/2014 | CN102188695B Ophthalmic gel composition |
| 01/22/2014 | CN101869172B Production method of active eel peptide |
| 01/22/2014 | CN101272801B 钙结合肽 Calcium binding peptide |
| 01/21/2014 | US8633305 Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules |
| 01/21/2014 | US8633303 Heterobifunctional pan-selectin inhibitors |
| 01/21/2014 | US8633297 Protein scaffolds |
| 01/21/2014 | US8633277 Methods for forming polymer-drug conjugates |
| 01/21/2014 | US8633230 Viral hepatitis treatment |
| 01/21/2014 | US8633198 Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
| 01/21/2014 | US8633175 Compounds as antagonists or inverse agonists at opioid receptors |
| 01/21/2014 | US8633164 Antimicrobial peptides |
| 01/21/2014 | US8633163 Template-fixed peptidomimetics |
| 01/21/2014 | US8633162 Methods of providing therapeutic effects using cyclosporin components |
| 01/21/2014 | US8633161 Therapeutic agents for the treatment of leukemia |
| 01/21/2014 | US8633160 Small molecule inhibitors of PDZ interactions |
| 01/21/2014 | US8633159 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 01/21/2014 | US8633158 Angiotensin in treating brain conditions |
| 01/21/2014 | US8633157 Glycopegylated erythropoietin |
| 01/21/2014 | US8633156 Insulin derivatives having an extremely delayed time-action profile |
| 01/21/2014 | US8633155 Methods of using angiopoietin-like 4 protein to stimulate proliferation of pre-adipocytes |
| 01/21/2014 | US8633153 Transthyretin variants |
| 01/21/2014 | US8633152 Process for making micro-sized protein particles |
| 01/21/2014 | US8633151 Ghrelin analogs |
| 01/21/2014 | US8633150 Methods for inducing sustained immune response |
| 01/21/2014 | US8633027 Knitted biodegradable silk fabric comprising yarn promoting ingrowth of cells and methods of making |
| 01/21/2014 | US8632997 RNA sequence-specific mediators of RNA interference |
| 01/21/2014 | US8632984 RBM3 as a marker for malignant melanoma prognosis |
| 01/21/2014 | US8632803 System for delivery of protein in insoluble fibrillar or aggregate form |
| 01/21/2014 | US8632801 Stable therapeutic formulations |
| 01/21/2014 | US8632786 Dose and localization of botulinum toxins in skin and muscle |
| 01/21/2014 | US8632785 Clostridial toxin pharmaceutical composition containing a gelatin fragment |
| 01/21/2014 | US8632784 Nucleic acids and proteins from Streptococcus pneumoniae |
| 01/21/2014 | US8632781 Immunogenic compounds comprising peptides of IL1β |
| 01/21/2014 | US8632780 Human complement C3 derivates with cobra venom factor-like function |
| 01/21/2014 | US8632779 S. aureus polypeptides and antibodies |
| 01/21/2014 | US8632778 Stabilized anti-interleukin-6 antibody-containing preparations |
| 01/21/2014 | US8632777 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen as diagnostic and therapeutic tools for prostate cancer |
| 01/21/2014 | US8632776 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies |
| 01/21/2014 | US8632771 High molecular weight derivatives of vitamin K-dependent polypeptides |
| 01/21/2014 | US8632770 Glycopegylated factor IX |
| 01/21/2014 | US8632769 Proteolytic enzyme formulations |
| 01/21/2014 | US8632565 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 01/21/2014 | CA2806698C Dietary supplement and methods of use thereof |
| 01/21/2014 | CA2722600C Anti-hepcidin antibodies and methods of use |
| 01/21/2014 | CA2698396C Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 01/21/2014 | CA2665748C Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/21/2014 | CA2595115C Fusion proteins for treating, preventing or ameliorating pain |
| 01/21/2014 | CA2427257C Expression vectors able to elicit improved immune response and methods of using same |
| 01/21/2014 | CA2418014C Immunotherapy for chronic myelocytic leukemia |
| 01/21/2014 | CA2414374C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/21/2014 | CA2388477C Recombinant gelatins with uniform molecular weight |
| 01/21/2014 | CA2371995C Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 01/21/2014 | CA2359317C Method of treating restenosis by antisense targeting of c-myc |
| 01/21/2014 | CA2341763C Antigenic peptides of aglyco 10b and antibodies thereto |
| 01/21/2014 | CA2311763C Method for producing human intervertebral disc cells |
| 01/16/2014 | WO2014012090A1 Molecular sleds comprising a positively-charged amino acid sequence and a molecular cargo and uses thereof |
| 01/16/2014 | WO2014012081A2 Chiral control |
| 01/16/2014 | WO2014012025A2 Igf-1 proteins and therapeutic uses thereof |
| 01/16/2014 | WO2014012001A2 Use of cart19 to deplete normal b cells to induce tolerance |
| 01/16/2014 | WO2014011993A2 Epitope spreading associated with car t-cells |
| 01/16/2014 | WO2014011988A2 Enhancing activity of car t cells by co-introducing a bispecific antibody |
| 01/16/2014 | WO2014011975A2 Micrornas sensitize cancers to therapy |
| 01/16/2014 | WO2014011971A2 Deuterated carfilzomib |
| 01/16/2014 | WO2014011917A2 A method of inhibiting tau phosphorylation |
| 01/16/2014 | WO2014011908A1 Apolipoprotein mixtures |
| 01/16/2014 | WO2014011813A1 Compositions containing hc-ha/ptx3 complexes and methods of use thereof |
| 01/16/2014 | WO2014011768A1 Anti-anxiety treatment |
| 01/16/2014 | WO2014011742A1 Method and composition for metabolic regulation |
| 01/16/2014 | WO2014011732A1 Compositions and methods for modulation of il-20 family cytokine activity |
| 01/16/2014 | WO2014011705A1 Vault immunotherapy |
| 01/16/2014 | WO2014011695A2 Prodrugs of peptide epoxy ketone protease inhibitors |
| 01/16/2014 | WO2014011672A1 Etanercept formulations exhibiting marked reduction in sub-visible particles |
| 01/16/2014 | WO2014011629A1 Stable aqueous formulations of etanercept |
| 01/16/2014 | WO2014011611A1 Topical formulations comprising dna repair enzymes, and methods of use thereof |
| 01/16/2014 | WO2014011573A2 Oligonucleotide inhibitors of dna methyltransferases and their use in treating diseases |
| 01/16/2014 | WO2014011177A1 Antisense p53 phosphorodiamidate morpholino composititons, methods and indications |
| 01/16/2014 | WO2014011052A1 Hypo-allergenic cross-linked proteins for use in the prevention of an allergy against milk-proteins and for use in the induction of oral tolerance |
| 01/16/2014 | WO2014010985A1 Peptide for highly efficient introduction and maintenance of intracellular protein |
| 01/16/2014 | WO2014010971A1 Cell-penetrating peptide, conjugate comprising same and composition comprising same |
| 01/16/2014 | WO2014010924A1 Pharmaceutical composition for topical administration comprising vancomycin or its salt and dexamethasone phosphate or its salt |
| 01/16/2014 | WO2014010890A1 An antibody composition for prevention or treatment of mutant hepatitis b virus infection |
| 01/16/2014 | WO2014010721A1 Method of producing self-assembling peptide derivative |
| 01/16/2014 | WO2014010614A1 Method for manufacturing microcapsule powder |
| 01/16/2014 | WO2014010586A1 Pharmaceutical preparation for injection |
| 01/16/2014 | WO2014010281A1 Drug for preventing/treating ocular disease |
| 01/16/2014 | WO2014010232A1 Ly6k epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014010231A1 Kif20a epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014010229A1 Cdca1 epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014009926A1 Pediatric oral liquid compositions containing nepadutant |
| 01/16/2014 | WO2014009774A1 Conjugates of cell binding molecules with cytotoxic agents |
| 01/16/2014 | WO2014009744A1 Colicins for treating bacterial infections |
| 01/16/2014 | WO2014009433A1 Mycobacterium resuscitation promoting factor for use as adjuvant |
| 01/16/2014 | WO2014009316A1 Novel use of insulin derivatives |